INFU
InfuSystem Holdings, IncCompany Information
- Company Name
- InfuSystem Holdings, Inc
- CIK
- CIK0001337013
- Category
- Accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- INFU: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 3841
- SIC Description
- Surgical & Medical Instruments & Apparatus
- Ticker
- INFU
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-05-11
- Last sale
- 2025-08-22
- Shares purchased (TTM)
- 27,031
- Shares sold (TTM)
- 5,752
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 14,288,481
- Shares outstanding
- 20,071,144
- Ownership
- 71.19%
Earnings Market Reaction
- Filing date
- 2026-08-04
- Price on filing date
- —
- 1-month reaction
- -2.27%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 1 | 2 | 3 | 1 | 1 | 2 | 1 | 0 | 0 | 1 | 0 | 0 | ||||||
| Accounts Receivable Net Current | 27 | 24 | 23 | 24 | 24 | 24 | 21 | 23 | 21 | 21 | 20 | 19 | ||||||
| Inventory Net | 6 | 6 | 5 | 6 | 6 | 6 | 7 | 7 | 7 | 6 | 6 | 6 | ||||||
| Other Assets Current | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 5 | 5 | 4 | 4 | ||||||
| Assets Current | 38 | 37 | 36 | 36 | 35 | 35 | 32 | 34 | 33 | 32 | 31 | 30 | ||||||
| Property Plant And Equipment Net | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
| Goodwill | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | ||||||
| Intangible Assets Net Excluding Goodwill | 6 | 7 | 7 | 7 | 7 | 6 | 6 | 7 | 7 | 7 | 7 | 8 | ||||||
| Operating Lease Right Of Use Asset | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 7 | 4 | ||||||
| Deferred Income Tax Assets Net | 4 | 4 | 5 | 5 | 6 | 7 | 7 | 8 | 9 | 9 | 9 | 9 | ||||||
| Derivative Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 2 | ||||||
| Other Assets Noncurrent | 2 | 2 | 2 | 0 | 0 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | ||||||
| Assets | 98 | 99 | 101 | 99 | 101 | 104 | 104 | 105 | 109 | 105 | 103 | 102 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 9 | 10 | 11 | 10 | 9 | 8 | 10 | 9 | 10 | 10 | 8 | 8 | ||||||
| Long Term Debt Current | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Other Liabilities Current | 6 | 8 | 9 | 9 | 7 | 8 | 8 | 8 | 6 | 8 | 8 | 7 | ||||||
| Liabilities Current | 15 | 17 | 20 | 19 | 16 | 16 | 18 | 17 | 16 | 17 | 16 | 14 | ||||||
| Long Term Debt Noncurrent | 20 | 20 | 20 | 21 | 26 | 29 | 24 | 28 | 34 | 30 | 29 | 33 | ||||||
| Operating Lease Liability Noncurrent | 3 | 3 | 3 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 6 | 4 | ||||||
| Liabilities | 39 | 40 | 43 | 43 | 46 | 49 | 46 | 50 | 55 | 53 | 51 | 51 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 119 | 119 | 117 | 116 | 115 | 115 | 114 | 113 | 111 | 111 | 110 | 109 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | ||||||
| Retained Earnings Accumulated Deficit | -61 | -61 | -61 | -61 | -62 | -61 | -57 | -58 | -59 | -60 | -59 | -59 | ||||||
| Stockholders Equity | 59 | 59 | 57 | 55 | 55 | 55 | 58 | 56 | 53 | 52 | 52 | 51 | ||||||
| Liabilities And Stockholders Equity | 98 | 99 | 101 | 99 | 101 | 104 | 104 | 105 | 109 | 105 | 103 | 102 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | ||||||
| Common Stock Shares Issued | 20 | 20 | 20 | 20 | 20 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | ||||||
| Shares Outstanding | 20 | 20 | 20 | 20 | 20 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialInfuSystem Holdings, Inc (INFU) — SEC Financial Statements & Analysis
InfuSystem Holdings, Inc (INFU) is a surgical & medical instruments & apparatus company, incorporated in DE. InfuSystem Holdings, Inc trades on NYSE as: INFU. InfuSystem Holdings, Inc (INFU)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04. Based on that filing, InfuSystem Holdings, Inc carries a market cap of $193.69M, a P/E ratio of 26.68x, a P/B ratio of 3.27x, a P/S ratio of 1.34x, an enterprise value of $213.15M, and an EV/EBITDA multiple of 8.68x. On profitability, it posts a gross margin of 56.69%, an operating margin of 8.52%, a net margin of 5.03%, a Return on Equity (ROE) of 12.77%, a Return on Assets (ROA) of 7.31%, and a Return on Invested Capital (ROIC) of 10.07%. Per share, it reports EPS of $0.36, diluted EPS of $0.35, free cash flow per share of $1.14, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 5.25% year-over-year, net income growth of 71.73% year-over-year, and EPS growth of 78.03% year-over-year. On the balance sheet, it maintains a current ratio of 2.50x, a quick ratio of 2.14x, working capital of $22.97M, a debt-to-equity ratio of 0.65x, a debt ratio of 0.39, an interest coverage ratio of 11.18x, free cash flow of $22.91M (TTM), and net debt of $19.46M. Figures sourced from SEC EDGAR.
- Market Cap
- $193.69M
- P/E TTM
- 26.68x
- EPS TTM
- $0.36
- P/B TTM
- 3.27x
- ROE TTM
- 12.77%
- ROA TTM
- 7.31%
- Debt To Equity
- 0.65x
- Free Cash Flow TTM
- $22.91M
- Net Revenue TTM Growth 1Y
- 5.25%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is InfuSystem Holdings, Inc in?
InfuSystem Holdings, Inc (INFU) operates in the Surgical & Medical Instruments & Apparatus industry.
What exchange does INFU trade on?
InfuSystem Holdings, Inc (INFU) trades on the NYSE.
Where is InfuSystem Holdings, Inc incorporated?
InfuSystem Holdings, Inc is incorporated in DE.
When was InfuSystem Holdings, Inc (INFU)'s most recent SEC filing?
InfuSystem Holdings, Inc (INFU)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-04.
What is INFU's market cap?
InfuSystem Holdings, Inc (INFU) has a market capitalization of $193.69M as of 2026-06-30.
What is INFU's P/E ratio?
InfuSystem Holdings, Inc (INFU)'s trailing twelve month P/E ratio is 26.68x as of 2026-06-30.
What is INFU's EPS (earnings per share)?
InfuSystem Holdings, Inc (INFU)'s trailing twelve month EPS is $0.36 as of 2026-06-30.
What is INFU's ROE (return on equity)?
InfuSystem Holdings, Inc (INFU)'s trailing twelve month Return on Equity (ROE) is 12.77% as of 2026-06-30.
What is INFU's ROA (return on assets)?
InfuSystem Holdings, Inc (INFU)'s trailing twelve month Return on Assets (ROA) is 7.31% as of 2026-06-30.
What is INFU's ROIC (return on invested capital)?
InfuSystem Holdings, Inc (INFU)'s trailing twelve month Return on Invested Capital (ROIC) is 10.07% as of 2026-06-30.
What is INFU's EV/EBITDA?
InfuSystem Holdings, Inc (INFU)'s trailing twelve month EV/EBITDA is 8.68x as of 2026-06-30.